TALK

Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions

2020
bit.bio panel discussion at ELRIG

 

bit.bio talk at ELRIG

Listen to the following experienced industry panellists

  • Kam Dhaliwal, SVP Alliance Management, bit.bio (chair)
  • Steve Rees, Vice President Discovery Biology, AstraZeneca
  • Benedict Cross, Chief Technology Officer, PhoreMost Ltd
  • Tilmann Buerckstuemmer, Chief Scientific Officer, Aelian Biotechnology GmbH
  • Marijn Vlaming, Head of Biology, Beerse & Leiden, Charles River Laboratories

who were brought together at ELRIG to engage in a thought-provoking discussion relating to new technologies within drug discovery and how they can accelerate the development of therapeutics, particularly in the area of cell therapy.

Download resource